SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-016940
Filing Date
2023-12-26
Accepted
2023-12-26 18:06:25
Documents
2
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 form3-12262023_111218.html 3  
1 form3-12262023_111218.xml 3 1682
2 ex24-12262023_111218.htm EX-24 6320
  Complete submission text file 0001415889-23-016940.txt   9491
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OLSHAN FROME WOLOSKY LLP 1325 AVENUE OF THE AMERICAS NEW YORK NY 10019
Business Address
Grant Jeremy T (Reporting) CIK: 0002004368 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 231514311